158 related articles for article (PubMed ID: 1694143)
1. Identification of a potent synthetic HIV1 immunogen compromising gag-P24 tandem T- and B-cell epitopes.
Chong P; Sia C; Sydor M; Klein M
FEBS Lett; 1990 May; 264(2):231-4. PubMed ID: 1694143
[TBL] [Abstract][Full Text] [Related]
2. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of the HIV-1 gag region by analysis of gag gene deletion fragments expressed in Escherichia coli defines eight antigenic determinants.
Marcus-Sekura CJ; Woerner AM; Zhang PF; Klutch M
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):317-27. PubMed ID: 1692722
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and immunological characterization of a 134-mer synthetic peptide corresponding to the N-terminal half of the HIV-1 nucleoprotein, p24.
Chong P; Sia C; Tam E; Kandil A; Klein M
Int J Pept Protein Res; 1993 Jan; 41(1):21-7. PubMed ID: 7679666
[TBL] [Abstract][Full Text] [Related]
5. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1.
Mills KH; Kitchin PA; Mahon BP; Barnard AL; Adams SE; Kingsman SM; Kingsman AJ
J Immunol; 1990 Mar; 144(5):1677-83. PubMed ID: 1689753
[TBL] [Abstract][Full Text] [Related]
6. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
[TBL] [Abstract][Full Text] [Related]
8. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
9. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
10. Nef and Gag synthetic peptide priming of antibody responses to HIV type 1 antigens in mice and primates.
Vaslin B; Claverie JM; Benveniste O; Barre-Sinoussi FC; Dormont D
AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1241-50. PubMed ID: 7531460
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A
J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
[TBL] [Abstract][Full Text] [Related]
13. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis.
Janvier B; Baillou A; Archinard P; Mounier M; Mandrand B; Goudeau A; Barin F
J Clin Microbiol; 1991 Mar; 29(3):488-92. PubMed ID: 1709947
[TBL] [Abstract][Full Text] [Related]
14. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
Madaule P; Gairin JE; Bénichou S; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
[TBL] [Abstract][Full Text] [Related]
15. Detection of HIV1 RNA and p24 antigen in HIV1-infected human liver.
Housset C; Lamas E; Bréchot C
Res Virol; 1990; 141(2):153-9. PubMed ID: 1971728
[TBL] [Abstract][Full Text] [Related]
16. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of a monoclonal antibody which binds HIV-1 Gag and not the Gag-derived proteins.
Sarubbi E; Denaro M
FEBS Lett; 1993 Dec; 335(3):335-7. PubMed ID: 7505237
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice.
Kion TA; Hoffmann GW
Science; 1991 Sep; 253(5024):1138-40. PubMed ID: 1909456
[TBL] [Abstract][Full Text] [Related]
19. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
[TBL] [Abstract][Full Text] [Related]
20. Specific antibody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection.
Jiang JD; Chu FN; Naylor PH; Kirkley JE; Mandeli J; Wallace JI; Sarin PS; Goldstein AL; Holland JF; Bekesi JG
J Acquir Immune Defic Syndr (1988); 1992; 5(4):382-90. PubMed ID: 1372353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
